Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02020681
Other study ID # P11-4-CURAF
Secondary ID 14934.1 PFLS-LS
Status Completed
Phase N/A
First received
Last updated
Start date September 2013
Est. completion date January 2016

Study information

Verified date August 2019
Source Credentis AG
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the therapeutic benefit of Curodont Repair for the treatment of early buccal carious lesions compared to placebo.


Description:

All study participants must have two early class V carious lesions in need of a treatment but not of an invasive treatment (split-mouth design). One lesion will be treated with Curodont Repair and one with placebo as control (single application). 3 months later fluoride (Duraphat) will be applied on both lesions. Study duration is 9 months. For assessment visual and tactile evaluation, pictures, ECM, Diagnodent Pen, Canary System, VAS is used.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date January 2016
Est. primary completion date January 2016
Accepts healthy volunteers No
Gender All
Age group 14 Years to 65 Years
Eligibility Inclusion Criteria:

- Two class V carious lesions which do not require an invasive treatment

- Size and form of the lesions: the lesions must both be fully visible and assessable and accessible

- Patients must be able and willing to observe good oral hygiene throughout the study

-= 20 teeth

- Permanent dentition and = 65 years

- Willing and able to attend the on-study visits

- Willing and able to understand all study-related procedures

- Written informed consent before participation in the study

- Negative pregnancy test for women of childbearing potential

Exclusion Criteria:

- The two study lesions must not be on adjacent teeth

- No adjacent restoration on study tooth surface

- Fluoride varnish application < 6 months prior to study treatment

- Patient suffers from diabetes

- Evidence of tooth erosion (due to excessive acidic drink consumption or reflux)

- History of head and neck illnesses (e.g. head/neck cancer)

- Any pathology or concomitant medication affecting salivary flow or dry mouth

- Any metabolic disorders affecting bone turnover

- Concurrent participation in another clinical trial with an investigational drug or device or participation in another clinical trial with an investigational drug or device within 30 days prior to study entry

- Pregnant and lactating woman

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Curodont Repair
Self-assembling peptide, biomimetic re-mineralisation
Other:
Placebo
Formulation of Curodont Repair without the peptide P11-4
Device:
Fluoride
Single application on day D90

Locations

Country Name City State
Switzerland University of Geneva - Devision of Cariology and Endodontology Geneva

Sponsors (1)

Lead Sponsor Collaborator
Credentis AG

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary The primary efficacy outcome is the difference of the change in the lesion size assessed by morphometry (standardised pictures) between investigational medical device and placebo group. Change of lesion size relative to baseline between study groups and different time points D0, D30, D90, D270
Secondary Difference in the change of Diagnodent Pen values between investigational medical device and placebo group. only descriptively analysed D0, D30, D90, D180, D270
Secondary Change in lesion's progression assessed by VAS between investigational medical device and placebo group. only descriptively analysed D0, D30, D90, D180, D270
See also
  Status Clinical Trial Phase
Completed NCT04127929 - Investigation of Glass Carbomer Performance N/A
Completed NCT04769882 - Er:YAG Laser Effects on Microbial Population in Conservative Dentistry N/A
Completed NCT04971317 - The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages N/A
Active, not recruiting NCT04475679 - Clinical Evaluation of Adhese Universal DC in the Indirect Restorative Therapy N/A
Completed NCT05438381 - Comparison of Clinical and Radiographic Outcomes of SMART Technique vs ART in Primary Molars N/A
Not yet recruiting NCT03037814 - Clinical Performance of Restorative Materials in Primary Teeth N/A
Active, not recruiting NCT05202665 - Resin Infiltration and Fluoride Varnish Lesion Arresting Efficacy on Non-cavitated Proximal Lesion N/A
Terminated NCT01147835 - Herbal Lollipops on Oral Bacterial Levels and DMFT/Dmft Scores of Children With Asthma Using Inhalers N/A
Not yet recruiting NCT04033263 - Maintaining Oral Health With Bio-products N/A
Enrolling by invitation NCT04438252 - Evaluation of Reliability of CarieScan PRO Compared With Digital Radiograph and ICDAS-II in Detection of Carious Lesions N/A
Not yet recruiting NCT03609034 - Knowledge, Attitude and Practice of a Group of Egyptian Dental Interns Toward Caries Risk Assessment
Completed NCT02912000 - TEACH: Technology Evaluation to Address Child Health N/A
Completed NCT02473107 - Impact of Detecting Initial and Active Caries Lesions in Primary Teeth N/A
Active, not recruiting NCT02537184 - Impact of Two Recall Intervals on Dental Caries Incidence and Other Outcomes of Preschool Children N/A
Completed NCT01950546 - Nanosilver Fluoride to Prevent Dental Biofilms Growth Phase 1
Recruiting NCT02734420 - Effect of Photodynamic Therapy With Low-level Laser on Infected Dentin in Primary Teeth: A Controlled Clinical Trial Phase 1
Completed NCT02234609 - Effectiveness of Modified Class IV Atraumatic Restorative Treatment N/A
Completed NCT02426619 - Arresting Active Dental Caries in Preschool Children by Topical Fluorides Phase 2/Phase 3
Withdrawn NCT01224002 - A Comparative Feasibility Study to Assess the Prevalence and Severity of Dental Caries in Incarcerated People Who Abuse Methamphetamine N/A
Completed NCT01268605 - Postoperative Hypersensitivity Randomized Comparative Effectiveness Research Trial Phase 3